Table 2.
OSDI changes during the trial.
| Time | FAS analysis | PPS analysis | ||
|---|---|---|---|---|
| Moxibustion group | Artificial tear group | Moxibustion group | Artificial tear group | |
| Baseline | 41.32 ± 22.41 | 37.38 ± 18.79 | 42.74 ± 22.49 | 36.21 ± 19.45 |
| Baseline—1 week | 4.00 ± 13.46△ | 4.78 ± 17.47 | 4.62 ± 14.04△ | 5.86 ± 18.36 |
| Baseline—2 week | 9.83 ± 16.15△ | 6.34 ± 18.14△ | 10.58 ± 16.43△ | 7.23 ± 18.75△ |
| Baseline—3 week | 11.39 ± 17.15△ | 8.88 ± 18.28△ | 12.36 ± 17.46△ | 9.71 ± 18.81△ |
| Baseline—4 week | 12.71 ± 17.23△ | 8.12 ± 18.45△ | 14.06 ± 17.55△ | 9.00 ± 20.16△ |
| End treatment-follow-up | −2.80 ± 16.29 | 4.47 ± 12.68 | −2.80 ± 16.29 | 4.35 ± 12.96 |
Note: OSDI: ocular surface disease index; △for P < 0.05, versus baseline within group; ∗for P < 0.05, versus artificial tear group at the same time point.